web analytics

Top 10 Big Pharma Advertisers vs Top 10 Big Pharma DOJ Fines

Top 10 Big Pharma Advertisers vs Top 10 Big Pharma DOJ Fines

May 18, 2015

Top 10 Big Pharma Advertisers Killing My Career

Top 10 Advertisers in Big Pharma

The Sociopathic Business Model™ maintains that companies that encourage, replicate and reward unethical and or illegal behavior will only change through forced accountability either through government intervention and or if their negative truth is exposed damaging the company image and in turn profits.

Big Pharma and Medical Device pay billion dollar fines without shame, remorse, or guilt and without accountability all at the expense of patients, consumers, employees and taxpayers alike.  This site has maintained that many in the industry would rather build billion dollar fines into annual budgets while again encouraging, replicating and rewarding employees who engage in unethical and or illegal activity on behalf of the company rather than actually fixing the problems within the organization.  Corruption & fraud are entrenched in the industry business model.

Johnson & Johnson’s constant rebranding or companies spending billions on direct to consumer advertising (DTC) campaigns are often ways for unethical companies, whose exposure of the negative truth they’d rather remain hidden caused damage to image and or profits, can try and mitigate the damages while still avoiding accountability and possibly distance from crimes by only focusing on company image.  As consumers this is something we should start (if we haven’t already) paying attention to and not rewarding companies that pathologically without accountability keep committing the same offenses at our expense.

Top 10 Big Pharma DOJ Fines Killing My Career

Top 10 Big Pharma DOJ Fines  vs Advertising Dollars 2014 Killing My Career

Johnson & Johnson Advertising spending from 2006 to 2014

Six of the top ten big pharma DTC advertisers are also the the DOJ’s list of highest paid pharma fines. It’s certainly inconsistent & contradictory language to action for Johnson & Johnson to spend $2.2 Billion in advertising in 2013 and of that $805 million in television dropped to $257.8 million for DTC television advertising in 2014.

Television is by far the most popular medium for DTC prescription drug advertising. It accounted for more than 70% of total spending from the top 10 pharma company dollars spent on advertising, or about $2.44 billion out of $3.4 billion, according to data supplied by Nielsen. Spending by all pharma companies was on an upswing in 2014, topping $4.5 billion, according to Nielsen data, which was an increase of 18% over the $3.8 billion spent in 2013.

Johnson & Johnson Advertising breakdown 2014

Perhaps because Johnson & Johnson through forced accountability has had to pay billions in fines and many victims are still working through the court system it also forced them to cut their advertising spending dramatically from one year to the next.

J&J Is Now Top-Fined Company in the Pharma/Med Device Criminal & Civil Settlement Planetary System: A Blot on Gorsky’s Leadership

 

 

 

1 Comment
  • CASE IN POINT…Look at this “Corporate Disclosure” of J&J filed in Florida. This is exactly what you are talking about where the attorney, Patricia Lowry, takes the position that Gynecare was “merged out of existence in 2000”. There are dozens of documents showing this not to be the truth. And, the question is: what exactly happens to the assets, liabilities, inventory, employees of that corporation? What happens to the corporation on the books? What kind of fancy accounting is it that “disappears” a corporation? J&J thinks I have not noticed. Now they know cause for sure they are reading this post. Ongoing part of their RICO conspiracy alleged by my lawsuit.

    This is the actual filing by the attorneys of Johnson & Johnson, Docket Number 27 filed on April 8, 2015…

    UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA
    CASE NUMBER: 1:15-cv-20442-JLK

    LANA C. KEETON,
    PLAINTIFF PRO SE

    V.

    JOHNSON & JOHNSON, ETHICON, INC., GYNECARE WORLDWIDE (NOW KNOWN AS ETHICON WOMEN’S HEALTH & UROLOGY [EWHU]), ETHICON SARL, PETER CECCHINI, JEFFREY B. SHAPIRO, NEVILLE M. LESLIE, ARNSTEIN & LEHR LLP, DR. G. WILLY DAVILA, DR. DELOS COSGROVE, THE CLEVELAND CLINIC FOUNDATION, DAVID KRAUSE, THE U.S. FOOD & DRUG ADMINISTRATION’S CENTER FOR DEVICES & RADIOLOGICAL HEALTH (FDA’S CDRH)
    DEFENDANTS/

    DEFENDANTS JOHNSON & JOHNSON AND ETHICON, INC.’S CORPORATE DISCLOSURE STATEMENT PURSUANT TO FEDERAL RULE 7.1

    Defendants Johnson & Johnson and Ethicon, Inc. submit their disclosure statement pursuant to Federal Rules of Civil Procedure, Rule 7.1 and state that:

    1. Johnson & Johnson has no parent corporation, and there is no publicly held corporation that owns 10% or more of Johnson & Johnson’s stock.

    2. Ethicon, Inc. is a wholly owned subsidiary of Johnson & Johnson, a publicly held corporation.

    3. Gynecare, Inc. (denominated as “Gynecare Worldwide” in the Complaint) no longer exists. Ethicon, Inc. acquired Gynecare, Inc., a business corporation organized under the laws of the State of Delaware with its principal place of business in California, on November 19, 1997. Gynecare, Inc. was merged out of existence and into Ethicon, Inc. on January 3, 2000.

    To the extent Plaintiff sues Gynecare as a division of Ethicon, Inc. an unincorporated division may not be sued. EEOC, Ethicon Women’s Health & Urology isnamed as a division of Ethicon, Inc. “[U]incorporated divisions of a corporation lack legal capacity to be sued.” EEOC v. St. Francis Xavier Parochial Sch., 77 F. Supp. 2d 71, 75 (D.D.C. 1999).

    Dated: April 8, 2015 Respectfully submitted,

    /s/ Patricia E. Lowry
    Patricia E. Lowry Florida Bar No. 332569
    E-Mail: patricia.lowry@squirepb.com
    SQUIRE PATTON BOGGS (US) LLP
    777 South Flagler Drive 1900 Phillips Point West
    West Palm Beach, FL 33401-6144 Telephone: 561-650-7200
    Facsimile: 561-655-1509

    Andrew R. Kruppa Florida Bar No. 63958
    Email: andrew.kruppa@squirepb.com
    SQUIRE PATTON BOGGS (US) LLP
    200 S. Biscayne Blvd., Ste. 4700
    Miami, FL 33131
    Telephone: 305-577-7000
    Facsimile: 305-577-7001

    Attorneys for Defendants Johnson & Johnson, Gynecare Worldwide, Ethicon, Inc., and Peter Cecchini

    May 18, 2015 at 9:55 pm

Post a Comment